PATENT CLAIM ANALYSIS

Application Number: 15860304
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "210080"]

Abstract:
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Claim (Index 14):
The method of  claim 10 , wherein the compound is or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 86.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15056137', '14515793', '13868703', '14056560', '15159378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8243014887755153
- 35 USC 102 Novelty (BERT): 0.5167893722966375
- Combined Prediction Score: 0.7935502771276276
- Mean Citation Score: 319.723744
- Max Citation Score: 328.6358
- Similarity Product: 295.33604126731166

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test